logo BDSP

Base documentaire

  1. Economic aspects of a general vaccination against invasive disease caused by Haemophilus influenzae type b (Hib) via the experience of the Children's Hospital La Fe, Valencia, Spain.

    Article - En anglais

    With the aim of studying whether a general vaccination against invasive disease caused by Haemophilus influenzae type b (Hib) is economically profitable bearing in mind the efficacy and safety of the vaccine, its price and the global cost that this disease has in our area, a review is conducted of patients admitted clue to invasive disease caused by Hib in the Chlldren's Hospital La Fe, Valencia, born between 1984 and 1993.

    They total 100,63 who have meningitis.

    In the 81 cases (56 with meningitis) born between 1984 and 1990 (years that can be regarded as « closed » since all the patients were younger than 5 years of age) the total cost has been calculated for hospitalization, care during the acute phase, care for the sequelae (6 severe and 7 mild) and death (5 cases).

    The mean annual cost of care can be calculated at 62 million pesetas, without making an economic valuation of the loss of life, and at 205 million pesetas taking this factor into account.

    The annual cost of vaccinating the 7000 babies under one year of age and falling within the Hospital's catchment area, on the basis of a vaccination pattern of three doses (at 2,4 and 6 months) or four closes (at 2,4,6 and 15 months) would amount to 63 or 84 million pesetas, normal price to public (not covered by National Health Service), and 40 or 51 million pesetas if acquired by National Health Service.

    As a conclusion we can state that, even from the economic point of view, without quantifying the cost of...

    Mots-clés Pascal : Haemophilus influenzae, Bactériose, Vaccination, Enfant, Aspect économique, Analyse avantage coût, Espagne, Pasteurellaceae, Bactérie, Infection, Homme, Europe, Pédiatrie

    Mots-clés Pascal anglais : Haemophilus influenzae, Bacteriosis, Vaccination, Child, Economic aspect, Cost benefit analysis, Spain, Pasteurellaceae, Bacteria, Infection, Human, Europe, Pediatrics

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0186580

    Code Inist : 002B30A01C. Création : 199608.